Astellas Pharma Inc. is a global pharmaceutical company focusing on therapeutic areas such as urology, oncology, and immunology. Founded in 2005, the company works on developing life-changing medicines for a wide array of health conditions.
Astellas Pharma develops and markets medicines targeting serious diseases such as cancer and immunological disorders.
The company integrates sustainability into its business strategy, with a focus on green initiatives and ethical research practices.
Astellas has a global presence, with operations in over 50 countries, including the U.S., Japan, and Europe.
Further Details
Some additional details about the company are listed below:
| Parameter | Details |
|---|---|
| Astellas Pharma Inc. | http://www.astellas.com |
| Company Name | Astellas Pharma Inc. |
| Solutions Offered | Oncology, urology, immunology, and neurological therapies |
| Sustainability Recognition | Commitment to sustainable healthcare and responsible practices |
| Key Technologies | Gene therapy, biologics, small molecule drugs |
| Industry | Pharmaceuticals |
| Core Focus | Development of innovative pharmaceutical treatments |
| Application Areas | Healthcare, oncology, immunology |
FAQs
Astellas specializes in oncology, urology, immunology, and neurological therapies.
Astellas uses gene therapy, biologics, and small molecule drug technologies.
Astellas is headquartered in Tokyo, Japan.
Astellas is committed to sustainable healthcare and responsible business practices.
Astellas serves global healthcare markets, focusing on oncology, immunology, and urology.